Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk
about
Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysisZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract.Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancerConditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate.Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer.Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.Genomic biomarkers, androgen pathway and prostate cancer.Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels.CAG Repeat Number in the Androgen Receptor Gene and Prostate Cancer.Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancerThe androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health StudyContribution of genetic variation rs266882 to prostate-specific antigen levels in healthy controls with serum PSA below 2.0 ng/ml.The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis.
P2860
Q33833804-85F7D77D-62A4-4EE2-945E-F7E0911BB2F6Q34031869-4499161F-B668-44F0-98BA-9D99AFF4758CQ34704983-3F785728-4649-4C85-9B3A-795C31CD5C76Q35312172-5E4A82A6-B3D7-4DA3-88FD-A5C159B49C53Q35947528-D6D132DA-C4D6-4395-BA01-B99CF5B5EB28Q36303157-91F100B7-62AA-4DB7-8A4A-F550034D61A0Q36758880-FA2D9F2D-CFE2-4617-B58D-308A0A92A5BFQ36845131-23F62B88-24FC-4DE6-8408-DB51D45164BDQ36977541-F0C683C9-1094-4EC5-A140-A534D277A020Q37181453-0077CB56-C766-402A-B293-17BB3653B79CQ37587629-D911ADD7-D880-4CDE-A197-33B61DFFEB0BQ41908642-B2D89B96-3D94-4D23-91C1-5A24FE7BB123Q42562784-24F31480-D22E-4D89-85D1-D0D571CE9C18Q45795121-1CF85B70-3D7B-4059-BF1C-A2614B26629AQ53085316-C5EB5422-C685-48FF-9A16-868FEE4A18CF
P2860
Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk
description
article
@en
im September 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2005
@uk
name
Polymorphisms in the androgen ...... genes and prostate cancer risk
@en
Polymorphisms in the androgen ...... genes and prostate cancer risk
@nl
type
label
Polymorphisms in the androgen ...... genes and prostate cancer risk
@en
Polymorphisms in the androgen ...... genes and prostate cancer risk
@nl
prefLabel
Polymorphisms in the androgen ...... genes and prostate cancer risk
@en
Polymorphisms in the androgen ...... genes and prostate cancer risk
@nl
P2093
P356
P1433
P1476
Polymorphisms in the androgen ...... genes and prostate cancer risk
@en
P2093
Claudia A Salinas
Janet L Stanford
Melissa A Austin
P356
10.1002/PROS.20230
P577
2005-09-01T00:00:00Z